Whereas in GTN-treated spheroid breast cancer MDA-MB-231 cells, EMT markers such as vimentin and N-cadherins were significantly downregulated, but the expression of E-cadherin was enhanced when compared to adherent breast cancer cells (Figure 5F,G). This evidence concerns the gene CDH2 and breast cancer.